Acquiring Company
Alkem Medtech
Acquired Company
Occlutech Holding AG
Description
Alkem Medtech Private Limited has signed an agreement to acquire a 51%-55% stake in Occlutech Holding AG. This acquisition, aimed at gaining a controlling interest, was formalized on June 26, 2026. The deal modifies the original Share Purchase Agreement from March 2026. This strategic move is part of Alkem Laboratories' efforts to expand its market reach.
Who to call at Alkem Medtech, and when
When Alkem Medtech changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alkem Medtech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alkem Medtech, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alkem Medtech makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Occlutech Holding AG?
Occlutech Holding AG was acquired by Alkem Medtech, based in Gujarat. The deal was reported on June 29, 2026. Alkem Medtech is a subsidiary of Alkem Laboratories focusing on medical technology. The company is dedicated to expanding its presence in the medtech industry through strategic acquisitions. Alkem Medtech is privately held and operates in Manufacturing.
When did Alkem Medtech acquire Occlutech Holding AG?
Alkem Medtech's acquisition of Occlutech Holding AG was reported on June 29, 2026. Alkem Medtech Private Limited has signed an agreement to acquire a 51%-55% stake in Occlutech Holding AG. This acquisition, aimed at gaining a controlling interest, was formalized on June 26, 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Occlutech Holding AG do?
Occlutech specializes in minimally invasive cardiac implants. Founded in 2003, it develops devices for treating congenital heart disease and other cardiovascular conditions. It is a major player in the European market for these devices. It is privately held, operating in Manufacturing, and is based in Switzerland.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.